BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4109415)

  • 21. TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
    JACOBSSON K; LANDBERG T
    Acta Chir Scand; 1964 Apr; 127():415-26. PubMed ID: 14149644
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma tartrate resistant acid phosphatase: a marker for osteoclastic bone resorption.
    Stĕpán JJ; Zichová M; Lachmanová J; Pacovský V
    Acta Univ Carol Med (Praha); 1986; 32(5-6):345-53. PubMed ID: 3439520
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
    Nakano S
    Hinyokika Kiyo; 1969 Aug; 15(8):565-75. PubMed ID: 4186705
    [No Abstract]   [Full Text] [Related]  

  • 24. ROC plots display test accuracy, but are still limited by the study design.
    Zweig MH
    Clin Chem; 1993 Jun; 39(6):1345-6. PubMed ID: 7684958
    [No Abstract]   [Full Text] [Related]  

  • 25. [Leukemia with positive reactions to tartrate-resistance acid phosphatase].
    Katayama I; Mochino T
    Rinsho Byori; 1983 Jul; 31(7):706-11. PubMed ID: 6361335
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of activity of acid phosphatase in serum in prostatic diseases].
    Ianishevskaia AD
    Lab Delo; 1967; 5():277-80. PubMed ID: 4184710
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
    Perrin P; Clairet F; Fleury-Goyon MC; Durand L
    J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of L-tartrate in determining prostatic serum acid phosphatase: a report of 514 cases.
    MATHES G; RICHMOND SG; SPRUNT DH
    Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):58-65. PubMed ID: 13274458
    [No Abstract]   [Full Text] [Related]  

  • 29. Circadian rhythm in serum acid phosphatase in young men with infravesical obstruction & elderly men with symptomatic prostatism.
    Mandal AK; Vaidyanathan S; Krishan K; Batra YK
    Indian J Med Res; 1988 Sep; 88():231-4. PubMed ID: 2465996
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Semeiological value of so-called prostatic tartrate-labile acid phosphatases. (Critical study of 500 medical records)].
    von Niederhäusern W; Tuchschmid D
    Ann Urol (Paris); 1970 Sep; 4(3):205-11. PubMed ID: 5472678
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum acid phosphatase activity in pathology].
    Paget M; Sanchez E; Vanneste A; Coustenoble P
    J Sci Med Lille; 1972; 90(8):283-94. PubMed ID: 4118620
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of iodination on the activity and structure of acid phosphomonoesterase from human prostate.
    Bobrzecka K; Ostrowski W; Rybarska J
    Acta Biochim Pol; 1968; 15(4):369-79. PubMed ID: 4181223
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acid phosphatase--how to read its figures].
    Ochiai K; Takeuchi H
    Nihon Rinsho; 1971 Jan; 29():Suppl:688-95. PubMed ID: 4929704
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer].
    Filmus J; Podhajcer OL; Mordoh J; Roca E; Cedaro L; Chacón RD
    Medicina (B Aires); 1982; 42(6 Pt 1):655-8. PubMed ID: 7183891
    [No Abstract]   [Full Text] [Related]  

  • 39. Radioimmunoassay of serum prostatic acid phosphatase in prostatic carcinoma. A comparative study with an enzymatic assay.
    Ishibe T
    Acta Urol Belg; 1981 Jan; 49(1):64-72. PubMed ID: 6163343
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.